S.R. Hirsch

5.3k total citations · 2 hit papers
73 papers, 4.1k citations indexed

About

S.R. Hirsch is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, S.R. Hirsch has authored 73 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Psychiatry and Mental health, 13 papers in Cognitive Neuroscience and 11 papers in Molecular Biology. Recurrent topics in S.R. Hirsch's work include Schizophrenia research and treatment (29 papers), Functional Brain Connectivity Studies (9 papers) and Bipolar Disorder and Treatment (8 papers). S.R. Hirsch is often cited by papers focused on Schizophrenia research and treatment (29 papers), Functional Brain Connectivity Studies (9 papers) and Bipolar Disorder and Treatment (8 papers). S.R. Hirsch collaborates with scholars based in United Kingdom, United States and Canada. S.R. Hirsch's co-authors include R. S. J. Frackowiak, Peter F. Liddle, Karl Friston, Chris Frith, Terry Jones, David J. Wright, Paul Wallace, Simon Wessely, Trudie Chalder and Ann Mortimer and has published in prestigious journals such as The Lancet, Brain and Biological Psychiatry.

In The Last Decade

S.R. Hirsch

71 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patterns of Cerebral Blood Flow in Schizophrenia

1992 714 citations Peter F. Liddle, Karl Friston et al. The British Journal of Psychiatry profile →
Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia

1998 574 citations L.J. Garey, Wei‐Yi Ong et al. Journal of Neurology Neurosurgery & Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S.R. Hirsch United Kingdom	28	2.1k	1.2k	804	633	562	73	4.1k
Stanley V. Catts Australia	36	1.6k 0.8×	2.0k 1.7×	500 0.6×	770 1.2×	533 0.9×	102	4.6k
Thomas Wobrock Germany	38	2.5k 1.2×	1.5k 1.3×	529 0.7×	862 1.4×	351 0.6×	125	4.9k
Ann Mortimer United Kingdom	28	2.1k 1.0×	1.2k 1.0×	674 0.8×	602 1.0×	504 0.9×	110	3.7k
Richard E. Powers United States	31	1.2k 0.6×	1.3k 1.1×	826 1.0×	377 0.6×	553 1.0×	68	3.8k
Markus Jäger Germany	37	2.1k 1.0×	1.4k 1.2×	469 0.6×	830 1.3×	622 1.1×	146	4.7k
Steven R. Hirsch United Kingdom	30	1.3k 0.6×	911 0.8×	416 0.5×	487 0.8×	302 0.5×	78	2.8k
Serge Sevy United States	37	2.3k 1.1×	1.5k 1.3×	849 1.1×	875 1.4×	311 0.6×	57	4.4k
William S. Stone United States	40	2.2k 1.1×	2.1k 1.8×	963 1.2×	811 1.3×	592 1.1×	183	5.1k
Alan I. Green United States	42	3.4k 1.6×	1.8k 1.5×	1.5k 1.9×	1.5k 2.3×	599 1.1×	100	7.0k
J.A. Lieberman United States	29	3.2k 1.6×	952 0.8×	1.4k 1.7×	718 1.1×	882 1.6×	50	5.2k

Countries citing papers authored by S.R. Hirsch

Since Specialization

Citations

This map shows the geographic impact of S.R. Hirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.R. Hirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.R. Hirsch more than expected).

Fields of papers citing papers by S.R. Hirsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.R. Hirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.R. Hirsch. The network helps show where S.R. Hirsch may publish in the future.

Co-authorship network of co-authors of S.R. Hirsch

This figure shows the co-authorship network connecting the top 25 collaborators of S.R. Hirsch. A scholar is included among the top collaborators of S.R. Hirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.R. Hirsch. S.R. Hirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, Matthew, Pankaj Sharma, Cameron Macdonald, et al.. (2018). Axonal myelin decrease in the splenium in major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience. 269(4). 387–395. 35 indexed citations

Williams, Matthew, et al.. (2015). Axonal myelin increase in the callosal genu in depression but not schizophrenia. Psychological Medicine. 45(10). 2145–2155. 13 indexed citations

Williams, Matthew, K.P. Galvin, Federico Turkheimer, et al.. (2013). Neuropathological changes in the substantia nigra in schizophrenia but not depression. European Archives of Psychiatry and Clinical Neuroscience. 264(4). 285–296. 38 indexed citations

Lyon, Gholson J., et al.. (2009). Aripiprazole in Children and Adolescents with Tourette's Disorder: An Open-Label Safety and Tolerability Study. Journal of Child and Adolescent Psychopharmacology. 19(6). 623–633. 51 indexed citations

Maycox, Peter R., F. M. Kelly, Adam Taylor, et al.. (2009). Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Molecular Psychiatry. 14(12). 1083–1094. 150 indexed citations

Hirsch, S.R., et al.. (2008). PANDAS and Paroxysms: A Case of Conversion Disorder?. Journal of Child and Adolescent Psychopharmacology. 18(1). 109–115. 7 indexed citations

Williams, Daniel T., S.R. Hirsch, & Barbara J. Coffey. (2007). Mood and Anxiety Symptoms in An Adolescent with Pervasive Developmental Disorder Not Otherwise Specified and Moderate Mental Retardation. Journal of Child and Adolescent Psychopharmacology. 17(5). 721–726. 1 indexed citations

Addington, Donald, Jean‐Michel Azorin, Ian R. H. Falloon, et al.. (2002). Clinical issues related to depression in schizophrenia: an international survey of psychiatrists. Acta Psychiatrica Scandinavica. 105(3). 189–195. 42 indexed citations

Garey, L.J., Wei‐Yi Ong, Tejesh Patel, et al.. (1998). Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. Journal of Neurology Neurosurgery & Psychiatry. 65(4). 446–453. 574 indexed citations breakdown →

10.

Wessely, Simon, Trudie Chalder, S.R. Hirsch, Paul Wallace, & David J. Wright. (1997). The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study.. American Journal of Public Health. 87(9). 1449–1455. 312 indexed citations

11.

Das, Indrajit, Nicole S. Khan, Basant K. Puri, & S.R. Hirsch. (1996). Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neuroscience Letters. 215(3). 209–211. 71 indexed citations

12.

Liddle, Peter F., Karl Friston, Chris Frith, et al.. (1992). Patterns of Cerebral Blood Flow in Schizophrenia. The British Journal of Psychiatry. 160(2). 179–186. 714 indexed citations breakdown →

13.

Friston, Karl, Peter F. Liddle, Chris Frith, S.R. Hirsch, & R. S. J. Frackowiak. (1992). THE LEFT MEDIAL TEMPORAL REGION AND SCHIZOPHRENIA: A PET STUDY. Brain. 115(2). 367–382. 225 indexed citations

14.

Das, Indrajit, et al.. (1992). Inositol phospholipid turnover in platelets of schizophrenic patients. Prostaglandins Leukotrienes and Essential Fatty Acids. 46(1). 65–66. 20 indexed citations

15.

Jolley, Anthony, et al.. (1990). Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years.. BMJ. 301(6756). 837–842. 126 indexed citations

16.

Das, Indrajit, et al.. (1990). The platelet polyphosphoinositide system in Schizophrenia: The effects of neuroleptic treatment. Biological Psychiatry. 28(6). 475–487. 40 indexed citations

17.

Hirsch, S.R. & T.R.E. Barnes. (1990). Testing the Efficacy of New Neuroleptic Drugs. PubMed. 8. 26–36. 4 indexed citations

18.

Jolley, Anthony, et al.. (1989). Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.. BMJ. 298(6679). 985–990. 99 indexed citations

19.

Hirsch, S.R., et al.. (1988). Psychiatric beds and resources : factors influencing bed use and service planning. 67 indexed citations

20.

Hirsch, S.R., R. Gaind, Palle Duun Rohde, Barbara C. Stevens, & J. K. Wing. (1973). Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo. BMJ. 1(5854). 633–637. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact